Sharda Cropchem Future Growth
Future criteria checks 4/6
Sharda Cropchem wird ein jährliches Wachstum der Erträge und Einnahmen um 59.8% bzw. 17.3% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich grow um 65.2% pro Jahr steigen. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 12% betragen.
Key information
59.8%
Earnings growth rate
65.2%
EPS growth rate
Chemicals earnings growth | 19.7% |
Revenue growth rate | 17.3% |
Future return on equity | 12.0% |
Analyst coverage | Good |
Last updated | 07 Feb 2024 |
Recent future growth updates
Recent updates
What Does Sharda Cropchem Limited's (NSE:SHARDACROP) Share Price Indicate?
Apr 04Need To Know: Analysts Just Made A Substantial Cut To Their Sharda Cropchem Limited (NSE:SHARDACROP) Estimates
Oct 27Analysts Just Made A Major Revision To Their Sharda Cropchem Limited (NSE:SHARDACROP) Revenue Forecasts
Jul 26Sharda Cropchem (NSE:SHARDACROP) Is Paying Out A Dividend Of ₹3.00
Jul 09Is It Too Late To Consider Buying Sharda Cropchem Limited (NSE:SHARDACROP)?
Jun 07Sharda Cropchem (NSE:SHARDACROP) Is Paying Out A Dividend Of ₹3.00
Jan 27At ₹498, Is Sharda Cropchem Limited (NSE:SHARDACROP) Worth Looking At Closely?
Dec 06Do Sharda Cropchem's (NSE:SHARDACROP) Earnings Warrant Your Attention?
Sep 22Sharda Cropchem's (NSE:SHARDACROP) Dividend Will Be ₹3.00
Jul 20Sharda Cropchem (NSE:SHARDACROP) Will Pay A Dividend Of ₹3.00
Jul 06When Should You Buy Sharda Cropchem Limited (NSE:SHARDACROP)?
Jun 15Is There An Opportunity With Sharda Cropchem Limited's (NSE:SHARDACROP) 41% Undervaluation?
May 31I Ran A Stock Scan For Earnings Growth And Sharda Cropchem (NSE:SHARDACROP) Passed With Ease
May 17Sharda Cropchem (NSE:SHARDACROP) Looks To Prolong Its Impressive Returns
Apr 01We Think Sharda Cropchem (NSE:SHARDACROP) Can Stay On Top Of Its Debt
Mar 03Calculating The Intrinsic Value Of Sharda Cropchem Limited (NSE:SHARDACROP)
Feb 12New Forecasts: Here's What Analysts Think The Future Holds For Sharda Cropchem Limited (NSE:SHARDACROP)
Jan 27Is It Too Late To Consider Buying Sharda Cropchem Limited (NSE:SHARDACROP)?
Jan 26Sharda Cropchem (NSE:SHARDACROP) Will Be Hoping To Turn Its Returns On Capital Around
Dec 27Increases to CEO Compensation Might Be Put On Hold For Now at Sharda Cropchem Limited (NSE:SHARDACROP)
Jul 22Here's Why I Think Sharda Cropchem (NSE:SHARDACROP) Might Deserve Your Attention Today
Jun 10Is It Time To Consider Buying Sharda Cropchem Limited (NSE:SHARDACROP)?
May 26Returns On Capital At Sharda Cropchem (NSE:SHARDACROP) Have Hit The Brakes
May 12Are You An Income Investor? Don't Miss Out On Sharda Cropchem Limited (NSE:SHARDACROP)
Apr 13We Think Sharda Cropchem (NSE:SHARDACROP) Can Manage Its Debt With Ease
Mar 30Has Sharda Cropchem Limited (NSE:SHARDACROP) Stock's Recent Performance Got Anything to Do With Its Financial Health?
Mar 16Have Insiders Been Buying Sharda Cropchem Limited (NSE:SHARDACROP) Shares?
Mar 01Should You Think About Buying Sharda Cropchem Limited (NSE:SHARDACROP) Now?
Feb 18Should You Be Adding Sharda Cropchem (NSE:SHARDACROP) To Your Watchlist Today?
Feb 08Results: Sharda Cropchem Limited Beat Earnings Expectations And Analysts Now Have New Forecasts
Jan 28Is Sharda Cropchem (NSE:SHARDACROP) Likely To Turn Things Around?
Jan 27Reflecting on Sharda Cropchem's (NSE:SHARDACROP) Share Price Returns Over The Last Three Years
Jan 18Key Things To Understand About Sharda Cropchem's (NSE:SHARDACROP) CEO Pay Cheque
Jan 06Why Sharda Cropchem Limited (NSE:SHARDACROP) Should Be In Your Dividend Portfolio
Dec 28Sharda Cropchem (NSE:SHARDACROP) Is Growing Earnings But Are They A Good Guide?
Dec 17We Think Sharda Cropchem (NSE:SHARDACROP) Can Manage Its Debt With Ease
Dec 07Is The Market Rewarding Sharda Cropchem Limited (NSE:SHARDACROP) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?
Nov 25Estimating The Fair Value Of Sharda Cropchem Limited (NSE:SHARDACROP)
Nov 16Sharda Cropchem Limited (NSE:SHARDACROP) Passed Our Checks, And It's About To Pay A ₹2.00 Dividend
Nov 04We're Watching These Trends At Sharda Cropchem (NSE:SHARDACROP)
Oct 20Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2026 | 46,771 | 3,263 | 2,057 | N/A | 6 |
3/31/2025 | 41,023 | 2,716 | 1,067 | N/A | 6 |
3/31/2024 | 31,452 | 801 | 550 | N/A | 3 |
12/31/2023 | 32,996 | 873 | N/A | N/A | N/A |
9/30/2023 | 37,176 | 1,910 | 785 | 3,267 | N/A |
6/30/2023 | 38,584 | 2,307 | N/A | N/A | N/A |
3/31/2023 | 40,452 | 3,420 | 842 | 3,283 | N/A |
12/31/2022 | 39,978 | 3,201 | N/A | N/A | N/A |
9/30/2022 | 38,603 | 3,139 | -565 | 2,064 | N/A |
6/30/2022 | 38,019 | 3,338 | N/A | N/A | N/A |
3/31/2022 | 35,798 | 3,493 | 333 | 2,671 | N/A |
12/31/2021 | 32,334 | 3,062 | N/A | N/A | N/A |
9/30/2021 | 28,474 | 2,523 | 1,084 | 3,349 | N/A |
6/30/2021 | 26,294 | 2,394 | N/A | N/A | N/A |
3/31/2021 | 23,956 | 2,292 | 152 | 2,464 | N/A |
12/31/2020 | 21,835 | 2,369 | N/A | N/A | N/A |
9/30/2020 | 20,722 | 1,945 | 1,144 | 2,972 | N/A |
6/30/2020 | 19,714 | 1,698 | N/A | N/A | N/A |
3/31/2020 | 20,030 | 1,647 | -297 | 1,463 | N/A |
12/31/2019 | 18,943 | 1,286 | N/A | N/A | N/A |
9/30/2019 | 19,824 | 1,431 | 1,925 | 3,855 | N/A |
6/30/2019 | 19,680 | 1,649 | N/A | N/A | N/A |
3/31/2019 | 19,976 | 1,763 | 4,131 | 5,561 | N/A |
12/31/2018 | 20,072 | 1,840 | N/A | N/A | N/A |
9/30/2018 | 18,612 | 1,736 | N/A | N/A | N/A |
6/30/2018 | 18,294 | 1,818 | N/A | N/A | N/A |
3/31/2018 | 17,066 | 1,908 | -1,848 | 170 | N/A |
12/31/2017 | 15,396 | 1,763 | N/A | N/A | N/A |
9/30/2017 | 14,571 | 1,840 | N/A | N/A | N/A |
6/30/2017 | 14,257 | 1,927 | N/A | N/A | N/A |
3/31/2017 | 13,992 | 1,904 | N/A | 1,815 | N/A |
12/31/2016 | 13,229 | 1,918 | N/A | N/A | N/A |
9/30/2016 | 12,663 | 1,861 | N/A | N/A | N/A |
6/30/2016 | 12,563 | 1,795 | N/A | N/A | N/A |
3/31/2016 | 12,221 | 1,751 | N/A | 1,966 | N/A |
12/31/2015 | 10,356 | 1,167 | N/A | N/A | N/A |
9/30/2015 | 10,402 | 1,136 | N/A | N/A | N/A |
6/30/2015 | 10,697 | 1,159 | N/A | N/A | N/A |
3/31/2015 | 10,616 | 1,230 | N/A | 461 | N/A |
12/31/2014 | 10,015 | 1,242 | N/A | N/A | N/A |
9/30/2014 | 9,605 | 1,207 | N/A | N/A | N/A |
6/30/2014 | 8,764 | 1,237 | N/A | N/A | N/A |
3/31/2014 | 7,904 | 1,111 | N/A | 1,563 | N/A |
Analyst Future Growth Forecasts
Einkommen vs. Sparrate: SHARDACROPDas prognostizierte Gewinnwachstum (31.9% pro Jahr) liegt über der Sparquote (6.7%).
Ertrag vs. Markt: SHARDACROPDie Erträge des Unternehmens (31.9% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Indian (16.4% pro Jahr).
Hohe Wachstumserträge: SHARDACROPEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.
Einnahmen vs. Markt: SHARDACROPDie Einnahmen des Unternehmens (12.4% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Indian (9.2% pro Jahr).
Hohe Wachstumseinnahmen: SHARDACROPDie Einnahmen des Unternehmens (12.4% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Earnings per Share Growth Forecasts
Future Return on Equity
Künftige Eigenkapitalrendite: SHARDACROPDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (12%).